Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study) | Synapse
April 3, 2019Open Access
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
Key Points
Key points are not available for this paper at this time.
Abstract
An amendment to this paper has been published and can be accessed via the original article.